Leo Wealth LLC Makes New Investment in CME Group Inc. (NASDAQ:CME)

Leo Wealth LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,177 shares of the financial services provider’s stock, valued at approximately $260,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in CME. Oak Harvest Investment Services raised its stake in shares of CME Group by 66.5% in the 1st quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock valued at $9,708,000 after acquiring an additional 18,017 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of CME Group by 21.2% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after buying an additional 8,443 shares during the last quarter. Duality Advisers LP bought a new stake in shares of CME Group during the 1st quarter worth $1,455,000. SG Americas Securities LLC grew its stake in CME Group by 312.2% in the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock valued at $12,222,000 after buying an additional 42,996 shares during the last quarter. Finally, Cetera Investment Advisers lifted its position in CME Group by 429.1% during the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after acquiring an additional 38,540 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

CME has been the topic of several research analyst reports. The Goldman Sachs Group raised their price target on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. Redburn Atlantic lowered CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a report on Tuesday, October 8th. TD Cowen assumed coverage on CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective for the company. Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research note on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $220.07.

CME Group Stock Down 0.4 %

Shares of CME opened at $226.17 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a 50-day moving average price of $217.70 and a two-hundred day moving average price of $208.53. The stock has a market cap of $81.44 billion, a price-to-earnings ratio of 25.73, a P/E/G ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.12.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. CME Group’s revenue was up 12.7% on a year-over-year basis. During the same quarter last year, the company earned $2.30 EPS. Equities analysts predict that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.03%. CME Group’s payout ratio is presently 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.